A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis (Q33753012)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

multicenter clinical trial

0 references

0 references

disseminated intravascular coagulation

0 references

Yuichiro Sakamoto

16

object named as

Yuichiro Sakamoto

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Satoshi Gando

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Daizoh Saitoh

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hiroyasu Ishikura

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Masashi Ueyama

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yasuhiro Otomo

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shigeto Oda

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shigeki Kushimoto

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Katsuhisa Tanjoh

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Toshihiko Mayumi

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Toshiaki Ikeda

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Toshiaki Iba

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yutaka Eguchi

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kohji Okamoto

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hiroshi Ogura

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kazuhide Koseki

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yasuhiro Takayama

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kunihiro Shirai

18

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Osamu Takasu

19

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yoshiaki Inoue

20

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kunihiro Mashiko

21

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Takaya Tsubota

22

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shigeatsu Endo

23

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group for the JAAM DIC Antithrombin Trial (JAAMDICAT)

24

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

16 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R297

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Severe sepsis, coagulation, and fibrinolysis: dead end or one way?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Expert consensus for the treatment of disseminated intravascular coagulation in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Serial evaluation of the SOFA score to predict outcome in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Clinical trial results with antithrombin III in sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Therapeutic rationale for antithrombin III in sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

APACHE II: a severity of disease classification system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

21 June 2018

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

1 reference

https://api.crossref.org/works/10.1186%2FCC13163

21 January 2018

High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety

1 reference

https://api.crossref.org/works/10.1186%2FCC13163

21 January 2018

Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial

1 reference

https://api.crossref.org/works/10.1186%2FCC13163

21 January 2018

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

1 reference

https://api.crossref.org/works/10.1186%2FCC13163

21 January 2018

Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey.

1 reference

https://api.crossref.org/works/10.1186%2FCC13163

21 January 2018

Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness

1 reference

https://api.crossref.org/works/10.1186%2FCC13163

21 January 2018

Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1186%2FCC13163

21 January 2018

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

30 October 2018

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

30 October 2018

Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057033

30 October 2018

Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24342495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24342495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24342495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24342495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24342495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24342495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/24342495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/CC13163

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33753012&oldid=2195738257"